News

The US FDA has granted IDE approval for Dymicron to commence a pivotal trial of its Triadyme-C cervical artificial disc ...
The US Patent and Trademark Office has granted a patent to Geneticure for its genetic test to predict response in renal denervation.
Ablation therapy represents a significant innovation in cancer care. Advanced thermocouple wires are helping to deliver ...
BVI is a winner in the Research and Development, Investments, and Product Launches categories in the 2025 Medical Device ...
ClearNote Health has secured the UK Conformity Assessed (UKCA) marking for the company's Avantect Pancreatic Cancer Test.
The US FDA has approved Boston Scientific’s expanded instructions for use (IFU) labelling of the Farapulse Pulsed Field Ablation (PFA) System.
The UK's National Institute for Health and Care Excellence (NICE) has formally recommended the use of Pulsed Field Ablation (PFA) for the treatment of atrial fibrillation (AF) within the NHS.
The US FDA has granted 510(k) clearance for Exactech’s Equinoxe Scapula Reconstruction System for acromial and scapular spine fractures.
USW researchers are set to develop biodegradable batteries that can be positioned in humans for powering medical implants.
MediView has announced the first patient enrolment in a study to assess the XR90 Holographic Surgical Navigation system.
Companion Spine has entered a definitive agreement to acquire Paradigm Spine’s business and assets from Xtant Medical Holdings.
Morphic Medical has obtained an EU CE mark for RESET, a device designed to target the underlying cause of obesity and type 2 diabetes (T2D).